Saturday 7 November 2026 Export XFOR’s income statement to Excel — free account

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.1 million, up 1,273.2% from fiscal 2024.

Revenue: +63.1%
EPS: +76.9%
Free cash flow: +27.5%
Total debt: +1.24%

Quarter to September 2026, against a year earlier

Insider buying

3.15 0.08 +2.61%

Follow XFOR

Alert me

Market cap: $304.4M
P/E: 0.0×
Fwd P/E: −4.8×
Dividend yield: —
F-score: n/a
Altman Z: −1.78
Beneish M: 8.05
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
ROE Full definition →	+8 more TTM periods Free account	(75.99%)	(104.21%)	(113.08%)	(80.32%)
ROA Full definition →		(36.25%)	(49.82%)	(50.32%)	(40.73%)
ROIC Full definition →		(566.65%)	(543.03%)	(226.62%)	(178.23%)
Return on Tangible Assets Full definition →		(33.56%)	(45.67%)	(45.16%)	(43.95%)
Average Days of Receivables Full definition →		5.96	45.07	47.15	31.63
Free Cash Flow per Share Full definition →		(2.10)	(0.74)	(0.70)	(0.64)
Free Cash Flow Full definition →		(88.62)	(92.85)	(88.74)	(81.10)
Capital Expenditures Full definition →		(3.00)	—	(5.00)	(5.00)
Other line items
Cash ROIC Full definition →		(17.19%)	(19.40%)	(20.16%)	(20.09%)
Accounts Receivable Turnover Full definition →		30.76	7.88	8.10	11.03
Accounts Payable Turnover Full definition →		0.80	0.20	0.50	0.62
Inventory Turnover Full definition →		1.58	0.42	0.68	0.65
Average Days of Payables Full definition →		361.13	1,129.74	490.07	576.54
Days of Inventory on Hand Full definition →		283.97	1,032.64	685.40	650.08
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		207.11%	772.80%	418.92%	367.86%
Selling, General and Administrative Expense of Revenue Full definition →		123.93%	393.40%	217.30%	187.86%
Share Based Compensation of Revenue Full definition →		12.24%	68.69%	53.83%	66.46%
Interest Coverage Full definition →		(9.79)	(11.10)	(10.06)	(9.26)
Operating CF/Net income Full definition →		1.08	0.93	0.93	0.95
Depreciation/Fixed assets Full definition →		7.02	7.01	15.01	31.12
Capex/Depreciation Full definition →		(2.35)	0.00	(3.00)	(2.82)
Revenue per Share Full definition →		0.83	0.07	0.13	0.13
Operating CF per Share Full definition →		(2.02)	(0.74)	(0.66)	(0.60)
Capex per Share Full definition →		(0.07)	0.00	(0.04)	(0.04)
Capex to Sales Full definition →		0.09	0.00	0.32	0.29

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly